These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 29414277)

  • 1. Post-Transplantation Lymphoproliferative Disorders in Adults.
    Dierickx D; Habermann TM
    N Engl J Med; 2018 Feb; 378(6):549-562. PubMed ID: 29414277
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-transplant lymphoproliferative disorders.
    Singavi AK; Harrington AM; Fenske TS
    Cancer Treat Res; 2015; 165():305-27. PubMed ID: 25655616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.
    Styczynski J; van der Velden W; Fox CP; Engelhard D; de la Camara R; Cordonnier C; Ljungman P;
    Haematologica; 2016 Jul; 101(7):803-11. PubMed ID: 27365460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Latest update on immunotherapy of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease].
    Hao QF; Sheng GY; Luan Z
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):795-9. PubMed ID: 24034931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.
    Pegoraro F; Favre C
    Ann Hematol; 2021 Apr; 100(4):865-878. PubMed ID: 33547921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH; Russ GR; Coates PT
    Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of Epstein-Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy.
    Raberahona M; Wackenheim C; Germi R; Carré M; Bulabois CE; Thiébaut A; Lupo J; Semenova T; Cahn JY; Morand P; Epaulard O
    Transpl Infect Dis; 2016 Dec; 18(6):889-895. PubMed ID: 27696681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant lymphoproliferative diseases.
    Gross TG; Savoldo B; Punnett A
    Pediatr Clin North Am; 2010 Apr; 57(2):481-503, table of contents. PubMed ID: 20371048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of post-transplant lymphoproliferative disorders.
    DeStefano CB; Desai SH; Shenoy AG; Catlett JP
    Br J Haematol; 2018 Aug; 182(3):330-343. PubMed ID: 29741774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disorders: from treatment to early detection and prevention?
    Bakker NA; van Imhoff GW
    Haematologica; 2007 Nov; 92(11):1447-50. PubMed ID: 18024391
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-transplant lymphoproliferative disorders.
    Dharnidharka VR; Webster AC; Martinez OM; Preiksaitis JK; Leblond V; Choquet S
    Nat Rev Dis Primers; 2016 Jan; 2():15088. PubMed ID: 27189056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome.
    Gross TG; Steinbuch M; DeFor T; Shapiro RS; McGlave P; Ramsay NK; Wagner JE; Filipovich AH
    Bone Marrow Transplant; 1999 Feb; 23(3):251-8. PubMed ID: 10084256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target.
    Tse E; Kwong YL
    Exp Mol Med; 2015 Jan; 47(1):e136. PubMed ID: 25613733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-associated post-transplantation lymphoproliferative disorder: potential treatments and implications for nursing practice.
    Jiménez S
    Clin J Oncol Nurs; 2015 Feb; 19(1):94-8. PubMed ID: 25689655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
    Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
    Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
    Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and posttransplant lymphoproliferative disease.
    Holmes R
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):442-4. PubMed ID: 11698760
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
    Hidalgo M; Lumbreras C; Aguado JM
    Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.
    Tsao SY; Chang KC; Chen YP; Yeh YM; Su WC; Chen TY
    Ann Hematol; 2011 Jan; 90(1):113-4. PubMed ID: 20369358
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.
    Al-Mansour Z; Nelson BP; Evens AM
    Curr Hematol Malig Rep; 2013 Sep; 8(3):173-83. PubMed ID: 23737188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.